Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Verona Pharma PlcADS | 6,315,933 | 6,392,106 | +76,173 | $181.71M | $296.85M | 8.27% | +$115.14M |
| Arcellx Inc COMMON STOCK | 3,888,669 | 3,478,888 | -409,781 | $324.74M | $266.80M | 7.43% | -$57.95M |
| Amicus Therapeutics Inc COM | 28,057,456 | 24,245,952 | -3,811,504 | $299.65M | $228.40M | 6.36% | -$71.26M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 3,560,214 | 3,680,473 | +120,259 | $186.52M | $206.03M | 5.74% | +$19.51M |
| Nuvalent Inc | 2,979,235 | 2,619,977 | -359,258 | $304.78M | $205.09M | 5.71% | -$99.68M |
| Iovance Biotherapeutics, Inc.(IOVA) | 26,617,709 | 22,112,266 | -4,505,443 | $249.94M | $163.63M | 4.56% | -$86.31M |
| Vaxcyte, Inc.(PCVX) | 2,027,608 | 1,718,417 | -309,191 | $231.69M | $140.67M | 3.92% | -$91.03M |
| Intra-Cellular Therapies Inc | 1,622,215 | 1,288,328 | -333,887 | $118.70M | $107.60M | 3.00% | -$11.10M |
| Centessa Pharmaceuticals PlcADS | 6,282,290 | 6,349,220 | +66,930 | $100.45M | $106.35M | 2.96% | +$5.90M |
| Praxis Precision Medicines, Inc.(PRAX) | 1,164,035 | 1,329,735 | +165,700 | $66.98M | $102.34M | 2.85% | +$35.36M |
| Artivion, Inc.(AORT) | 2,793,703 | 2,793,703 | 0 | $74.37M | $79.87M | 2.23% | +$5.50M |
| MeiraGTx Holdings plc(MGTX) | 12,581,103 | 12,581,103 | 0 | $52.43M | $76.58M | 2.13% | +$24.15M |
| Edgewise Therapeutics, Inc.(EWTX) | 2,330,294 | 2,685,537 | +355,243 | $62.20M | $71.70M | 2.00% | +$9.51M |
| Soleno Therapeutics Inc | 3,204,976 | 1,501,040 | -1,703,936 | $161.82M | $67.47M | 1.88% | -$94.35M |
| Immatics N.V.SHS(IMTX) | 8,086,159 | 9,383,456 | +1,297,297 | $92.26M | $66.72M | 1.86% | -$25.55M |
| Insulet Corporation(PODD) | 142,269 | 232,269 | +90,000 | $33.11M | $60.64M | 1.69% | +$27.53M |
| Spyre Therapeutics, Inc.(SYRE) | 2,872,547 | 2,574,723 | -297,824 | $84.48M | $59.94M | 1.67% | -$24.54M |
| Astria Therapeutics Inc | 6,485,420 | 6,485,420 | 0 | $71.40M | $57.98M | 1.62% | -$13.42M |
| Evolus, Inc.(EOLS) | 5,356,622 | 5,145,846 | -210,776 | $86.78M | $56.81M | 1.58% | -$29.97M |
| Axsome Therapeutics, Inc.(AXSM) | 782,844 | 664,074 | -118,770 | $70.35M | $56.19M | 1.57% | -$14.17M |
| Cargo Therapeutics Inc | 3,683,004 | 3,683,004 | 0 | $67.95M | $53.11M | 1.48% | -$14.84M |
| Immunovant, Inc.(IMVT) | 2,378,762 | 2,139,199 | -239,563 | $67.82M | $52.99M | 1.48% | -$14.83M |
| Protagonist Therapeutics Inc | 1,374,563 | 1,271,662 | -102,901 | $61.86M | $49.09M | 1.37% | -$12.77M |
| Apogee Therapeutics Inc | 2,015,007 | 1,047,232 | -967,775 | $118.36M | $47.44M | 1.32% | -$70.92M |
| Aldeyra Therapeutics, Inc.(ALDX) | 9,275,851 | 9,275,851 | 0 | $50.00M | $46.29M | 1.29% | -$3.71M |
| Janux Therapeutics, Inc.(JANX) | 0 | 817,895 | +817,895 | $0 | $43.79M | 1.22% | +$43.79M |
| argenx SEADR(ARGX) | 118,839 | 67,471 | -51,368 | $64.42M | $41.49M | 1.16% | -$22.93M |
| Viking Therapeutics, Inc.(VKTX) | 1,699,987 | 995,894 | -704,093 | $107.63M | $40.07M | 1.12% | -$67.55M |
| Akero Therapeutics Inc | 1,714,806 | 1,185,592 | -529,214 | $49.20M | $32.98M | 0.92% | -$16.21M |
| Intuitive Surgical, Inc.(ISRG) | 58,119 | 63,119 | +5,000 | $28.55M | $32.95M | 0.92% | +$4.39M |
| Acrivon Therapeutics Inc | 5,360,858 | 5,360,858 | 0 | $37.53M | $32.27M | 0.90% | -$5.25M |
| Zymeworks Inc.(ZYME) | 2,180,020 | 2,130,020 | -50,000 | $27.36M | $31.18M | 0.87% | +$3.82M |
| Celcuity Inc.(CELC) | 2,362,279 | 2,362,279 | 0 | $35.22M | $30.92M | 0.86% | -$4.30M |
| Viridian Therapeutics, Inc.(VRDN) | 2,812,665 | 1,486,508 | -1,326,157 | $63.99M | $28.50M | 0.79% | -$35.49M |
| Solid Biosciences Inc | 6,906,646 | 6,906,646 | 0 | $48.14M | $27.63M | 0.77% | -$20.51M |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 2,125,649 | 6,774,348 | +4,648,699 | $6.89M | $25.61M | 0.71% | +$18.72M |
| PROCEPT BioRobotics Corporation(PRCT) | 315,659 | 290,659 | -25,000 | $25.29M | $23.40M | 0.65% | -$1.89M |
| Nautilus Biotechnology, Inc.(NAUT) | 12,594,211 | 12,594,211 | 0 | $35.89M | $21.16M | 0.59% | -$14.74M |
| Contineum Therapeutics, Inc.CL A(CTNM) | 1,516,668 | 1,441,249 | -75,419 | $29.03M | $21.11M | 0.59% | -$7.91M |
| Natera, Inc.(NTRA) | 220,000 | 125,000 | -95,000 | $27.93M | $19.79M | 0.55% | -$8.14M |
| Inhibikase Therapeutics, Inc.(IKT) | 0 | 5,925,000 | +5,925,000 | $0 | $19.26M | 0.54% | +$19.26M |
| Orchestra BioMed Holdings, Inc.(OBIO) | 4,592,556 | 4,592,556 | 0 | $23.61M | $18.37M | 0.51% | -$5.24M |
| Penumbra, Inc.(PEN) | 0 | 73,338 | +73,338 | $0 | $17.42M | 0.49% | +$17.42M |
| Septerna, Inc.(SEPN) | 0 | 750,000 | +750,000 | $0 | $17.18M | 0.48% | +$17.18M |
| Oruka Therapeutics, Inc.(ORKA) | 1,235,187 | 845,567 | -389,620 | $30.27M | $16.40M | 0.46% | -$13.88M |
| Inhibrx Biosciences, Inc.(INBX) | 1,064,026 | 1,064,026 | 0 | $16.66M | $16.39M | 0.46% | -$276.6K |
| Adma Biologics Inc | 1,060,200 | 890,280 | -169,920 | $21.19M | $15.27M | 0.43% | -$5.93M |
| Bright Minds Biosciences Inc.(DRUG) | 0 | 403,649 | +403,649 | $0 | $14.54M | 0.41% | +$14.54M |
| Arvinas, Inc.(ARVN) | 1,027,749 | 740,749 | -287,000 | $25.31M | $14.20M | 0.40% | -$11.11M |
| Neurocrine Biosciences, Inc.(NBIX) | 212,228 | 100,050 | -112,178 | $24.45M | $13.66M | 0.38% | -$10.80M |
| Dyne Therapeutics, Inc.(DYN) | 718,144 | 543,277 | -174,867 | $25.80M | $12.80M | 0.36% | -$13.00M |
| Xenon Pharmaceuticals Inc.(XENE) | 524,930 | 325,324 | -199,606 | $20.67M | $12.75M | 0.36% | -$7.91M |
| Merus N V | 300,000 | 300,000 | 0 | $14.99M | $12.62M | 0.35% | -$2.37M |
| CG Oncology, Inc.(CGON) | 733,695 | 419,450 | -314,245 | $27.68M | $12.03M | 0.34% | -$15.65M |
| Anteris Technologies Global Corp.(AVR) | 0 | 2,140,000 | +2,140,000 | $0 | $11.94M | 0.33% | +$11.94M |
| EyePoint, Inc.(EYPT) | 1,037,274 | 1,537,274 | +500,000 | $8.29M | $11.45M | 0.32% | +$3.16M |
| Edwards Lifesciences Corp | 0 | 145,000 | +145,000 | $0 | $10.73M | 0.30% | +$10.73M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 1,296,416 | 186,662 | -1,109,754 | $42.64M | $10.34M | 0.29% | -$32.30M |
| Adagio Medical Holdings, Inc.(ADGM) | 9,812,419 | 9,812,419 | 0 | $25.32M | $10.30M | 0.29% | -$15.01M |
| Insmed Incorporated(INSM) | 180,000 | 144,000 | -36,000 | $13.14M | $9.94M | 0.28% | -$3.20M |
| Crinetics Pharmaceuticals In | 724,698 | 184,525 | -540,173 | $37.03M | $9.43M | 0.26% | -$27.60M |
| Rapt Therapeutics Inc | 0 | 5,880,000 | +5,880,000 | $0 | $9.29M | 0.26% | +$9.29M |
| Ocular Therapeutix, Inc.(OCUL) | 3,324,468 | 1,078,495 | -2,245,973 | $28.92M | $9.21M | 0.26% | -$19.71M |
| Inari Med Inc | 0 | 178,797 | +178,797 | $0 | $9.13M | 0.25% | +$9.13M |
| OnKure Therapeutics, Inc.CL A(OKUR) | 0 | 1,004,439 | +1,004,439 | $0 | $8.64M | 0.24% | +$8.64M |
| Nurix Therapeutics, Inc.(NRIX) | 0 | 330,614 | +330,614 | $0 | $6.23M | 0.17% | +$6.23M |
| Zenas BioPharma, Inc.(ZBIO) | 1,144,035 | 744,035 | -400,000 | $19.36M | $6.09M | 0.17% | -$13.26M |
| iRhythm Holdings, Inc.(IRTC) | 22,591 | 65,153 | +42,562 | $1.68M | $5.87M | 0.16% | +$4.20M |
| Rapport Therapeutics, Inc.(RAPP) | 748,183 | 311,551 | -436,632 | $15.32M | $5.53M | 0.15% | -$9.80M |
| Helix Acquisition Corp IiCL A | 500,000 | 500,000 | 0 | $5.22M | $5.25M | 0.15% | +$25.1K |
| Rocket Pharmaceuticals, Inc.(RCKT) | 931,851 | 378,584 | -553,267 | $17.21M | $4.76M | 0.13% | -$12.45M |
| CeriBell, Inc.(CBLL) | 0 | 180,546 | +180,546 | $0 | $4.67M | 0.13% | +$4.67M |
| Veru Inc.(VERU) | 7,283,157 | 6,483,157 | -800,000 | $5.60M | $4.22M | 0.12% | -$1.38M |
| Mereo BioPharma Group plcADS(MREO) | 815,722 | 1,085,512 | +269,790 | $3.35M | $3.80M | 0.11% | +$446.7K |
| Perspective Therapeutics, Inc.(CATX) | 0 | 1,190,263 | +1,190,263 | $0 | $3.80M | 0.11% | +$3.80M |
| Lineage Cell Therapeutics, Inc.(LCTX) | 0 | 7,236,843 | +7,236,843 | $0 | $3.64M | 0.10% | +$3.64M |
| Biodesix, Inc.(BDSX) | 2,173,880 | 2,173,880 | 0 | $3.87M | $3.33M | 0.09% | -$543.5K |
| Athira Pharma Inc | 5,402,964 | 5,402,964 | 0 | $2.41M | $3.17M | 0.09% | +$760.2K |
| PepGen Inc.(PEPG) | 1,410,438 | 829,536 | -580,902 | $12.06M | $3.14M | 0.09% | -$8.92M |
| ImmunityBio, Inc.(IBRX) | 0 | 1,221,734 | +1,221,734 | $0 | $3.13M | 0.09% | +$3.13M |
| Bicycle Therapeutics PlcADS | 255,994 | 197,108 | -58,886 | $5.79M | $2.76M | 0.08% | -$3.03M |
| Lyra Therapeutics Inc | 12,757,562 | 12,757,562 | 0 | $3.28M | $2.63M | 0.07% | -$650.6K |
| Verrica Pharmaceuticals Inc.(VRCA) | 7,099,182 | 3,249,669 | -3,849,513 | $10.29M | $2.27M | 0.06% | -$8.02M |
| Forte Biosciences Inc | 95,742 | 95,742 | 0 | $535.2K | $2.17M | 0.06% | +$1.64M |
| Scpharmaceuticals Inc | 0 | 500,000 | +500,000 | $0 | $1.77M | 0.05% | +$1.77M |
| Trinity Biotech plcADR(TRIB) | 1,800,000 | 1,790,000 | -10,000 | $1.98M | $1.58M | 0.04% | -$404.8K |
| Traws Pharma, Inc.(TRAW) | 0 | 164,157 | +164,157 | $0 | $1.46M | 0.04% | +$1.46M |
| Fulcrum Therapeutics, Inc.(FULC) | 0 | 238,000 | +238,000 | $0 | $1.12M | 0.03% | +$1.12M |
| Lexeo Therapeutics, Inc.(LXEO) | 139,835 | 139,835 | 0 | $1.26M | $920.1K | 0.03% | -$344.0K |
| Nanobiotix S.A.ADS(NBTX) | 555,066 | 266,093 | -288,973 | $3.19M | $763.7K | 0.02% | -$2.43M |
| Applied Therapeutics Inc | 8,005,000 | 860,000 | -7,145,000 | $68.04M | $736.3K | 0.02% | -$67.31M |
| Ensysce Biosciences, Inc.(ENSC) | 0 | 86,666 | +86,666 | $0 | $705.5K | 0.02% | +$705.5K |
| Delcath Systems, Inc.(DCTH) | 0 | 50,000 | +50,000 | $0 | $602.0K | 0.02% | +$602.0K |
| Pyxis Oncology, Inc.(PYXS) | 508,462 | 188,462 | -320,000 | $1.87M | $294.0K | 0.01% | -$1.57M |
| Apyx Medical Corporation(APYX) | 0 | 150,000 | +150,000 | $0 | $237.0K | 0.01% | +$237.0K |
| Revolution Medicines, Inc.W EXP 12 17 202(RVMD) | 250,000 | 250,000 | 0 | $35.0K | $45.0K | 0.00% | +$10.0K |
| Surrozen, Inc.W EXP 08 01 203(SRZN) | 166,666 | 166,666 | 0 | $1.7K | $3.6K | 0.00% | +$1.9K |
| Absci Corporation | 700,000 | 0 | -700,000 | $2.67M | $0 | — | -$2.67M |
| Allogene Therapeutics Inc | 2,725,000 | 0 | -2,725,000 | $7.63M | $0 | — | -$7.63M |
| Arcutis Biotherapeutics, Inc.(ARQT) | 1,358,500 | 0 | -1,358,500 | $12.63M | $0 | — | -$12.63M |